294 related articles for article (PubMed ID: 16918404)
21. Efficient delivery of nucleic acid molecules into skin by combined use of microneedle roller and flexible interdigitated electroporation array.
Huang D; Zhao D; Wang X; Li C; Yang T; Du L; Wei Z; Cheng Q; Cao H; Liang Z; Huang Y; Li Z
Theranostics; 2018; 8(9):2361-2376. PubMed ID: 29721085
[No Abstract] [Full Text] [Related]
22. Recent advances in magnetofection and its potential to deliver siRNAs in vitro.
Mykhaylyk O; Zelphati O; Hammerschmid E; Anton M; Rosenecker J; Plank C
Methods Mol Biol; 2009; 487():111-46. PubMed ID: 19301645
[TBL] [Abstract][Full Text] [Related]
23. Self-assembling complexes between binary mixtures of lipids with different linkers and nucleic acids promote universal mRNA, DNA and siRNA delivery.
Colombani T; Peuziat P; Dallet L; Haudebourg T; Mével M; Berchel M; Lambert O; Habrant D; Pitard B
J Control Release; 2017 Mar; 249():131-142. PubMed ID: 28159514
[TBL] [Abstract][Full Text] [Related]
24. Magnetically enhanced nucleic acid delivery. Ten years of magnetofection-progress and prospects.
Plank C; Zelphati O; Mykhaylyk O
Adv Drug Deliv Rev; 2011 Nov; 63(14-15):1300-31. PubMed ID: 21893135
[TBL] [Abstract][Full Text] [Related]
25. Nonviral approach for targeted nucleic acid delivery.
Jafari M; Soltani M; Naahidi S; Karunaratne DN; Chen P
Curr Med Chem; 2012; 19(2):197-208. PubMed ID: 22320298
[TBL] [Abstract][Full Text] [Related]
26. Strategy for selecting nanotechnology carriers to overcome immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeutics.
Dobrovolskaia MA; McNeil SE
Expert Opin Drug Deliv; 2015 Jul; 12(7):1163-75. PubMed ID: 25994601
[TBL] [Abstract][Full Text] [Related]
27. Towards Self-Transfecting Nucleic Acid Nanostructures for Gene Regulation.
Gudipati S; Zhang K; Rouge JL
Trends Biotechnol; 2019 Sep; 37(9):983-994. PubMed ID: 30879697
[TBL] [Abstract][Full Text] [Related]
28. Enhancing and targeting nucleic acid delivery by magnetic force.
Plank C; Anton M; Rudolph C; Rosenecker J; Krötz F
Expert Opin Biol Ther; 2003 Aug; 3(5):745-58. PubMed ID: 12880375
[TBL] [Abstract][Full Text] [Related]
29. Recent advances in nanoparticle-mediated siRNA delivery.
Williford JM; Wu J; Ren Y; Archang MM; Leong KW; Mao HQ
Annu Rev Biomed Eng; 2014 Jul; 16():347-70. PubMed ID: 24905873
[TBL] [Abstract][Full Text] [Related]
30. Nanobiotechnology: an efficient approach to drug delivery of unstable biomolecules.
Amaral AC; Felipe MS
Curr Protein Pept Sci; 2013 Nov; 14(7):588-94. PubMed ID: 23968343
[TBL] [Abstract][Full Text] [Related]
31. Novel drug delivery system by surface modified magnetic nanoparticles.
Takeda S; Terazono B; Mishima F; Nakagami H; Nishijima S; Kaneda Y
J Nanosci Nanotechnol; 2006; 6(9-10):3269-76. PubMed ID: 17048546
[TBL] [Abstract][Full Text] [Related]
32. Innovative nanotechnologies for the delivery of oligonucleotides and siRNA.
Toub N; Malvy C; Fattal E; Couvreur P
Biomed Pharmacother; 2006 Nov; 60(9):607-20. PubMed ID: 16952435
[TBL] [Abstract][Full Text] [Related]
33. Enhancement of the efficiency of non-viral gene delivery by application of pulsed magnetic field.
Kamau SW; Hassa PO; Steitz B; Petri-Fink A; Hofmann H; Hofmann-Amtenbrink M; von Rechenberg B; Hottiger MO
Nucleic Acids Res; 2006; 34(5):e40. PubMed ID: 16540591
[TBL] [Abstract][Full Text] [Related]
34. Applications of Spherical Nucleic Acid Nanoparticles as Delivery Systems.
Mokhtarzadeh A; Vahidnezhad H; Youssefian L; Mosafer J; Baradaran B; Uitto J
Trends Mol Med; 2019 Dec; 25(12):1066-1079. PubMed ID: 31703931
[TBL] [Abstract][Full Text] [Related]
35. Nucleic acid delivery using magnetic nanoparticles: the Magnetofection technology.
Laurentt N; Sapet C; Le Gourrierec L; Bertosio E; Zelphati O
Ther Deliv; 2011 Apr; 2(4):471-82. PubMed ID: 22826855
[TBL] [Abstract][Full Text] [Related]
36. Exosomes as natural delivery carriers for programmable therapeutic nucleic acid nanoparticles (NANPs).
Ke W; Afonin KA
Adv Drug Deliv Rev; 2021 Sep; 176():113835. PubMed ID: 34144087
[TBL] [Abstract][Full Text] [Related]
37. Barcoded nanoparticles for high throughput in vivo discovery of targeted therapeutics.
Dahlman JE; Kauffman KJ; Xing Y; Shaw TE; Mir FF; Dlott CC; Langer R; Anderson DG; Wang ET
Proc Natl Acad Sci U S A; 2017 Feb; 114(8):2060-2065. PubMed ID: 28167778
[TBL] [Abstract][Full Text] [Related]
38. Update on Nanotechnology-based Drug Delivery Systems in Cancer Treatment.
Ho BN; Pfeffer CM; Singh ATK
Anticancer Res; 2017 Nov; 37(11):5975-5981. PubMed ID: 29061776
[TBL] [Abstract][Full Text] [Related]
39. Recent in vivo advances in cell-penetrating peptide-assisted drug delivery.
Kurrikoff K; Gestin M; Langel Ü
Expert Opin Drug Deliv; 2016; 13(3):373-87. PubMed ID: 26634750
[TBL] [Abstract][Full Text] [Related]
40. Intracellular Delivery of Molecular Cargo Using Cell-Penetrating Peptides and the Combination Strategies.
Li H; Tsui TY; Ma W
Int J Mol Sci; 2015 Aug; 16(8):19518-36. PubMed ID: 26295227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
